Literature DB >> 1624742

Cinchonism: two case reports and review of acute quinine toxicity and treatment.

L R Wolf1, E J Otten, M P Spadafora.   

Abstract

Two cases of acute quinine toxicity are presented, one from self-poisoning and the other from an unidentified source. Both patients presented with acute bilateral blindness. They also experienced the classic symptoms of cinchonism, including nausea, vomiting, and tinnitus. Prolongation of the Q-T interval developed in both patients. Serum quinine levels of 5.3 mg/L and 13 mg/L were measured. Although their visual acuity improved, both patients had some residual deficit at follow-up. A review of the literature, including clinical presentation and emergency medicine diagnosis and management, is also presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624742     DOI: 10.1016/0736-4679(92)90336-r

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  5 in total

1.  The antimalarial drug quinine disrupts Tat2p-mediated tryptophan transport and causes tryptophan starvation.

Authors:  Combiz Khozoie; Richard J Pleass; Simon V Avery
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

Review 2.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

3.  Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis.

Authors:  Thierry Rolling; Dominic Wichmann; Stefan Schmiedel; Gerd D Burchard; Stefan Kluge; Jakob P Cramer
Journal:  Malar J       Date:  2013-07-15       Impact factor: 2.979

Review 4.  New developments in anti-malarial target candidate and product profiles.

Authors:  Jeremy N Burrows; Stephan Duparc; Winston E Gutteridge; Rob Hooft van Huijsduijnen; Wiweka Kaszubska; Fiona Macintyre; Sébastien Mazzuri; Jörg J Möhrle; Timothy N C Wells
Journal:  Malar J       Date:  2017-01-13       Impact factor: 2.979

5.  Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo.

Authors:  Henry M T Ntuku; Gianfrancesco Ferrari; Christian Burri; Antoinette K Tshefu; Didier M Kalemwa; Christian Lengeler
Journal:  Malar J       Date:  2016-01-08       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.